$21.86
-0.47-2.10%
At close: -
$21.98
0.120.55%
After Hours: 7:56 PM EDT
Comments
Loading...
ADMA Biologics Earnings Estimates, EPS & Revenue | NASDAQ:ADMA | Benzinga
ADMA Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$0.140
Quarterly Revenue Estimate
$116.40M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$426.45M
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADMA | ADMA Biologics | $0.08 | $0.14 | — | — | $81.88M | $116.40M | — | — | 05/08/2025 | Get Alert |
| ADMA | ADMA Biologics | $0.04 | $0.15 | $0.14 | -6.67% | $73.90M | $112.80M | $117.55M | 4.21% | 03/03/2025 | Get Alert |
| ADMA | ADMA Biologics | $0.01 | $0.13 | $0.15 | 15.38% | $67.28M | $105.85M | $119.84M | 13.22% | 11/07/2024 | Get Alert |
| ADMA | ADMA Biologics | -$0.03 | $0.08 | $0.13 | 62.50% | $60.12M | $86.41M | $107.19M | 24.05% | 08/08/2024 | Get Alert |
| ADMA | ADMA Biologics | -$0.03 | $0.05 | $0.08 | 60.00% | $56.91M | $77.27M | $81.88M | 5.96% | 05/09/2024 | Get Alert |
| ADMA | ADMA Biologics | -$0.06 | $0.02 | $0.04 | 100.00% | $49.98M | $72.15M | $73.90M | 2.43% | 02/28/2024 | Get Alert |
| ADMA | ADMA Biologics | -$0.08 | -$0.01 | $0.01 | 200.00% | $41.09M | $62.12M | $67.28M | 8.30% | 11/08/2023 | Get Alert |
| ADMA | ADMA Biologics | -$0.07 | -$0.02 | -$0.03 | -50.00% | $33.91M | $55.50M | $60.12M | 8.33% | 08/09/2023 | Get Alert |
| ADMA | ADMA Biologics | -$0.10 | -$0.04 | -$0.03 | 25.00% | $29.10M | $53.41M | $56.91M | 6.56% | 05/10/2023 | Get Alert |
| ADMA | ADMA Biologics | -$0.09 | -$0.06 | -$0.06 | 0.00% | $26.38M | $45.93M | $49.98M | 8.82% | 03/23/2023 | Get Alert |
| ADMA | ADMA Biologics | -$0.13 | -$0.08 | -$0.08 | 0.00% | $20.68M | $34.48M | $41.09M | 19.17% | 11/09/2022 | Get Alert |
| ADMA | ADMA Biologics | -$0.14 | -$0.08 | -$0.07 | 12.50% | $17.83M | $31.81M | $33.91M | 6.59% | 08/10/2022 | Get Alert |
| ADMA | ADMA Biologics | -$0.16 | -$0.08 | -$0.10 | -25.00% | $16.05M | $27.69M | $29.10M | 5.10% | 05/11/2022 | Get Alert |
| ADMA | ADMA Biologics | -$0.21 | -$0.09 | -$0.09 | 0.00% | $13.96M | $21.76M | $26.38M | 21.25% | 03/24/2022 | Get Alert |
| ADMA | ADMA Biologics | -$0.19 | -$0.14 | -$0.13 | 7.14% | $10.28M | $18.72M | $20.68M | 10.48% | 11/10/2021 | Get Alert |
| ADMA | ADMA Biologics | -$0.23 | -$0.15 | -$0.14 | 6.67% | $7.79M | $16.42M | $17.83M | 8.59% | 08/11/2021 | Get Alert |
| ADMA | ADMA Biologics | -$0.26 | -$0.17 | -$0.16 | 5.88% | $10.20M | $14.58M | $16.05M | 10.08% | 05/12/2021 | Get Alert |
| ADMA | ADMA Biologics | -$0.18 | -$0.16 | -$0.21 | -31.25% | $12.04M | $12.91M | $13.96M | 8.10% | 03/25/2021 | Get Alert |
| ADMA | ADMA Biologics | -$0.19 | -$0.19 | -$0.19 | 0.00% | $7.22M | $9.96M | $10.28M | 3.17% | 11/05/2020 | Get Alert |
| ADMA | ADMA Biologics | -$0.25 | -$0.16 | -$0.23 | -43.75% | $6.56M | $10.57M | $7.79M | -26.32% | 08/05/2020 | Get Alert |
| ADMA | ADMA Biologics | -$0.28 | -$0.12 | -$0.26 | -116.67% | $3.53M | $10.88M | $10.20M | -6.25% | 05/06/2020 | Get Alert |
ADMA Biologics (ADMA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $0.14 | $0.15 | -6.67 % |
| Q3 | 2024-11-07 | $0.15 | $0.13 | 15.4 % |
| Q2 | 2024-08-08 | $0.13 | $0.08 | 62.5 % |
| Q1 | 2024-05-09 | $0.08 | $0.05 | 60.0 % |
ADMA Biologics (ADMA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $117.55M | $112.80M | 4.21 % |
| Q3 | 2024-11-07 | $119.84M | $105.85M | 13.2 % |
| Q2 | 2024-08-08 | $107.19M | $86.41M | 24.1 % |
| Q1 | 2024-05-09 | $81.88M | $77.27M | 5.96 % |
FAQ
When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?
ADMA Biologics (ADMA) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for ADMA Biologics (NASDAQ:ADMA)?
The Actual EPS was $0.14, which missed the estimate of $0.15.
What were ADMA Biologics’s (NASDAQ:ADMA) revenues?
The Actual Revenue was $117.5M, which beat the estimate of $112.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
